Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If ...

Read more about Future pandemics may be fought faster with mRNA and advanced vaccine platforms on Devdiscourse ...

Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...

Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle ...

Add Yahoo as a preferred source to see more of our stories on Google. COVID-19 mRNA vaccines create enough of an immunity boost to extend survival in certain types of lung and skin cancers, an ...

Moderna (NASDAQ:MRNA) has agreed to pay US$950 million to resolve a long-running patent dispute tied to the technology used ...

With the U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. canceling nearly $500 million in mRNA vaccine research contracts on Tuesday, you may be wondering if mRNA vaccines are safe.

A settlement provides a massive windfall for Arbutus and Roivant and avoids a worst-case scenario for Moderna.

The American College of Physicians (ACP) has recommended that adults aged 65 years or older receive updated 2025–2026 mRNA-based COVID-19 vaccines, according to February guidelines published in Annals ...

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

The committee’s reputation has taken a nosedive, however, following HHS Secretary Robert F. Kennedy Jr.’s decision to purge ...